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Edited by S. KowalczykowskiAbstractLegend: Escherichia coli topo IV uses a segmented DNA
binding domain to discriminate between positively and
negatively supercoiled substrates. The different chiral
writhes of two plasmid DNAs are depicted (positive, right;
negative, left), with a schematic of how topo IV (pink oval)
may use its DNA binding domains (green spheres) to
differentially bind to the two types of DNA crossovers. The
structure of the DNA binding domain (bottom) can be
divided into distinct regions that are necessary for overall
function (“on”), contribute to rapid relaxation activity
(“fast”), or impede enzyme activity (“slow”). Artwork by
Rachel Davidowitz, Freelance Scientific Illustrator.Type IIA DNA topoisomerases are essential en-
zymes that use ATP to maintain chromosome
supercoiling and remove links between sister chro-
mosomes. In Escherichia coli, the type IIA topo-
isomerase topo IV rapidly removes positive
supercoils and catenanes from DNA but is signifi-
cantly slower when confronted with negatively
supercoiled substrates. The ability of topo IV to
discriminate between positively and negatively
supercoiled DNA requires the C-terminal domain
(CTD) of one of its two subunits, ParC. To determine
how the ParC CTD might assist with substrate
discrimination, we identified potential DNA interact-
ing residues on the surface of the CTD, mutated
these residues, and tested their effect on both topo
IV enzymatic activity and DNA binding by the
isolated domain. Surprisingly, different regions of
the ParC CTD do not bind DNA equivalently, nor
contribute equally to the action of topo IV on different
types of DNA substrates. Moreover, we find that the
CTD contains an autorepressive element that in-
hibits activity on negatively supercoiled and cate-
nated substrates, as well as a distinct region that
aids in bending the DNA duplex that tracks through
the enzyme's nucleolytic center. Our data demon-
strate that the CTD is essential for proper engage-
ment of both gate and transfer segment DNAs,
reconciling different models to explain how topo IV
discriminates between distinct DNAs topologies.
© 2013 Elsevier Ltd. All rights reserved.atter © 2013 Elsevier Ltd. All rights reserved. J. Mol. Biol. (2013) 425, 3029–3045
3030 Topo IV ParC CTD Controls Substrate DiscriminationIntroductionDNA topoisomerases are ubiquitous and essential
enzymes that maintain the topological homeostasis
of chromosomes. Type IIA topoisomerases use ATP
to modulate chromosome supercoiling and interlink-
ing (catenation) by binding and cleaving one duplex
DNA (termed the gate segment or G-segment),
passing another duplex DNA (the transfer segment
or T-segment) through the transient opening, and
religating the break [1–4]. Since the type IIA
topoisomerase catalytic cycle has the potential to
create toxic, double-stranded DNA breaks, topoi-
somerases are highly regulated to ensure proper
activity and localization. Regulation can be mediated
both intrinsically, through specific physical elements
and post-translational modifications, and extrinsical-
ly, through direct physical interactions with other
proteins (for review, see Ref. [5]). The regulatory
programs that define type IIA topoisomerase func-
tion on specific substrates or during particular
periods of the cell cycle are still emerging.
Most bacteria encode two type IIA topoisomerase
paralogs, gyrase and topoisomerase IV (topo IV)
[6–8]. Gyrase and topo IV share a common
heterotetrameric architecture (GyrA2⋅GyrB2 or
ParE2⋅ParC2), as well as substantial sequence
homology. Despite these similarities, however,
gyrase and topo IV perform distinct functions.
Gyrase actively introduces negative supercoils into
DNA to counteract the introduction of positive
supercoils by processes such as replication and
transcription [6,9]. By contrast, topo IV preferentially
removes positive supercoils and resolves cate-
nanes from DNA formed during DNA replication
but is less active on negatively supercoiled sub-
strates [10–15].
The functional differences between gyrase and
topo IV have been ascribed (at least in part) to
variations in the C-terminal domains (CTDs) of their
respective GyrA and ParC subunits. The GyrA and
ParC CTD share a common β-pinwheel fold that is
formed by a series of repeating Greek key motifs or
“blades” (Fig. 1a and b) [18–20]. The GyrA CTD is a
DNA binding and wrapping domain composed of six
blades [20–22], along with a conserved motif known
as the “GyrA-box”, which can latch the first blade of
the domain to the last blade [23,24]. Loss of either
the GyrA CTD or the GyrA box abolishes the ability
of gyrase to supercoil DNA but does not abrogate
strand passage [25–27]. ParC CTDs can bind but
not wrap DNA substrates, and have a variable
number of blades (from three to eight, proteobacter-
ial versions possess five) [18,20,28]. Although the
ParC CTD does not contain a canonical GyrA box,
degenerate remnants of the motif are found in each
of its blades (Fig. 1a and Supplementary Fig. 1) [28].
Loss of the Escherichia coli ParC CTD does not
completely abolish relaxation and decatenation bytopo IV but does generally disrupt the ability of the
enzyme to distinguish between topologically distinct
substrates [20].
How topo IV discriminates positively supercoiled
DNAs from negatively supercoiled substrates has
been a subject of debate. In one study, multiple DNA
molecules were braided at the single-molecule level
to simulate crossovers found in positively and
negatively supercoiled substrates. These experi-
ments found that topo IV relaxed crossovers found
in positively supercoiled substratesmore readily than
crossovers found in negatively supercoiled DNAs,
suggesting that specificity was determined by an
ability of the enzyme to sense the chirality of G- and
T-segment crossing angles within the topo IV active
site [10]. A subsequent single-molecule study set out
to test this model by assaying the ability of topo IV to
act on a variety of crossover angles between only two
DNA duplexes, rather than braids; however, these
experiments found that topo IV showed no prefer-
ence for positive versus negative crossovers [14] and
that discrimination instead arose from differences in
enzyme processivity on positively and negatively
supercoiled substrates [14]. In yet a third effort,
structural and biochemical studies of ParC have
suggested that the CTD may associate with T-
segment DNAs and hence provide a means to
influence activity [20].
To better understand how the ParC CTD might aid
in topology discrimination by E. coli topo IV, we
mutated potential DNA interacting residues on the
positively charged outer surface of the domain and
tested the effect of these substitutions on enzyme
function. Unexpectedly, we found that distinct re-
gions of the ParC CTD contribute differentially to
DNA binding affinity and the action of topo IV on
specific types of DNA substrates. Some sites appear
to actively repress activity on negatively supercoiled
and catenated substrates, whereas others are more
important for functions such as G-segment bending.
Together, these studies indicate that topo IV can
indeed sense the juxtaposition of G- and T-segment
crossovers but that this discrimination—which acts
in part through controlling enzyme processivity—
occurs outside the active site where strand passage
takes place.Results
Construction and solution behavior of ParC
CTD mutants
Although the CTD of E. coli ParC has been shown
to be important in topology discrimination by topo IV
[20], the mechanism of this effect has remained
unknown. The CTDs of ParC and GyrA have been
suggested to bind DNA using the positively charged
3031Topo IV ParC CTD Controls Substrate Discriminationrim that encircles the domain [18–20,29] (Fig. 1c). To
more finely dissect the role of this region, we set out to
identify prospective DNA binding residues using
multiple-sequence alignments of ParC CTD homo-
logs that contain only five blades. We focused first on
residues that are both highly conserved and positively
charged (Supplementary Fig. 1) and mapped these
residues onto theE. coliParCCTD crystal structure to
find surface-exposed amino acids that did not appear
to be required for structural stability. This analysis
revealed that many of the most highly conserved
positions reside in degenerate GyrA-box motifs that
reside on the extended loops that latch adjoining
blades together (Fig. 1d and Supplementary Fig. 1).
We also identified a positively charged patch on the
fifth blade that contains two arginines previously
suggested to interact with the E. coli condensin
homolog, MukB (Arg705 and Arg729) [30,31].
Given the criteria described above, we next
mutated representative basic residues from each of
the five blades to aspartate, using charge sub-
stitutions to actively disfavor potential electrostaticFig. 1. ParC CTD structure and organization. (a) Primary s
blades of the ParC CTD are colored according to number. A c
spots correspond to positions assayed in this work). (b) Cartoo
[Protein Data Bank (PDB) ID: 1ZVT], top and side views. Resid
All figures depicting crystal structures were generated in PyMO
CTD crystal structure (PDB ID: 1ZVT) outer surface, top and si
positive charges. (d) Sequence conservation of γ-proteobacte
Sequence logos generated in enoLOGOs [17]. Residues asses
complete sequence alignment, see Supplementary Fig. 1.interactions that might occur with DNA. Full-length
ParCmutants were purified to homogeneity and then
subjected to size-exclusion chromatography to con-
firm that the introduced mutations did not cause the
proteins to aggregate (Supplementary Fig. 2).Of all the
mutations surveyed, only one (Arg721Asp) did not
behave as a monodisperse species and so was
discarded; interestingly, this locus lies in close
proximity to a previously identified ParC temperature-
sensitive allele, Gly725Asp [8]. An alternative residue
within this region, Arg723Asp, which is nearly as
well conserved (Supplementary Fig. 1), was chosen
in lieu of Arg721 and found to behave as per the
wild-type (WT) protein in solution. To ensure that the
CTD mutants were properly folded at the tempera-
tures used in our enzymatic assays, we measured
circular dichroism (CD) spectra for each mutant at
25 °C and 37 °C (Supplementary Fig. 2). In each
case, the CD spectra for all mutants were similar to
that of WT ParC, indicating that the substitutions did
not lead to gross perturbations in protein structure
(Supplementary Fig. 2).tructure of ParC. The ParC NTD is colored gray and the
artoon schematic of the ParC CTD is on the right (colored
n representation of the E. coli ParC CTD crystal structure
ues assayed in this work are shown by stick representation.
L [16]. (c) Electrostatic representation of the E. coli ParC
de views. The outer, curved surface of the domain is rich in
rial ParC CTD residues residing in remnant GyrA boxes.
sed in this work are indicated under each logo. For a more
3032 Topo IV ParC CTD Controls Substrate DiscriminationConserved, basic amino acids in the ParC CTD
are important for positive-supercoil relaxation
After purifying our CTD mutants, we proceeded to
conduct enzyme assays for standard topo IV
activities on different types of DNA substrates
using native agarose gel electrophoresis. In the
absence of a DNA intercalating agent, supercoiled
DNA migrates faster than intermediate, relaxed, and
nicked topoisomers through the gel matrix. We
initially tested the ability of our ParC mutants to
relax topo IV's favored substrate, positively super-
coiled DNA. Different concentrations of enzyme
were titrated against a fixed concentration of DNA
to look for general defects in activity (Fig. 2). We
discovered that mutations within the CTD of ParC
exhibited a broad range of activity profiles, ranging
from essentially WT behavior to severe defects in the
efficiency and/or processivity of supercoil relaxation
[a detailed explanation of topoisomerase processiv-
ity is provided in Supplementary Fig. 3; relative
defects in processivity are roughly quantified by
comparing the amount of mutant topo IV required to
produce a final topoisomer distribution similar to that
seen for the WT enzyme (boxed in blue, Fig. 2)]. For
example, mutation of positions within blade 5Fig. 2. General activity of WT andmutant topo IVs on positive
shown in each panel. Each assay proceeded for 10 min p
supercoiled plasmid and various concentrations of each topo IV
indicated above each gel. A schematic of the topoisomer distr
correspond to the enzyme concentration at which WT topo
topoisomer distribution and is shown for reference. Asteri
positive-supercoil relaxation time course (Fig. 3).(Arg705Asp/Arg729Asp) resulted in no change in
activity or processivity, whereas mutation of blade 1
(Arg564Asp) significantly impaired both (~10-fold
decrease). Other mutations primarily affected en-
zyme processivity; substitutions to blades 2–4
(Arg616Asp, Lys665Asp, Arg723Asp) led to partic-
ularly distributive behavior.
To further characterize the effects of ParC CTD
mutations on positively supercoiled DNA, we looked
at relaxation using a fixed molar excess of DNA
compared to topo IV (~50-fold) as a function of time.
This regime permitted us to observe differences in
rate of relaxation in addition to changes in processiv-
ity. Interestingly, all mutations tested actually mod-
estly enhanced the overall rate of positive-supercoil
relaxation by topo IV compared to the WT protein,
with the exception of Arg564Asp in blade 1, which
was severely compromised (Fig. 3). As with the
enzyme titration assays, however, defects in proces-
sivity were again observed for mutations in blades 2
and 3, and, to a lesser extent, blade 4. Together,
these data demonstrate that positively charged
amino acids on the CTD of ParC not only influence
the activity of topo IV on positively supercoiled DNA
but also unexpectedly show that different blades
make different contributions to activity.ly supercoiled DNA substrate. The constructs assayed are
rior to quenching and contained 7.9 nM of a positively
construct (0.005–50 nM), with the ratio of topo IV to DNA
ibution is illustrated on the left side of the gels. Blue boxes
IV removes all positive supercoils and reaches its final
sks indicate the concentration of protein used for the
3033Topo IV ParC CTD Controls Substrate DiscriminationBasic residueson theParCCTDdifferentially affect
decatenation and negative-supercoil relaxation
We next tested the ability of our ParC CTD
mutants to act on kinetoplast DNA (kDNA), which
forms networks of ~5000 2.5-kb minicircles that are
a favored substrate of topo IV [32–35]. When
visualized by agarose gel electrophoresis, the
kDNA network is too large to pass into the gel
matrix and remains trapped in the wells; however, in
the presence of topo IV or other topoisomerases,
kDNA minicircles are released into the gel matrix
[36]. Although the processivity of topo IV on kDNA
cannot be evaluated in this assay, the activity of the
enzyme can be monitored as an increase in the
amount of minicircle produced as a function of
either protein concentration or time. We first
examined the ability of different quantities of topo
IV to decatenate the substrate at a fixed concen-
tration of kDNA (Fig. 4). As with the relaxation of
positively supercoiled DNA, mutations in the ParC
CTD exhibited a broad range of functional effects.
Mutation of blades 2 and 4 had only a modest effect
on decatenation. By contrast, mutation of blade 3
markedly reduced enzymatic activity (~10-fold),
while the blade 1 substitution almost entirely
abrogated minicircle release. Unexpectedly, the
blade 5 mutation appeared to increase the activity
of topo IV on kDNA nearly 10-fold (as indicated by aFig. 3. Rate of positive-supercoil relaxation by WT and mu
panel. Assays contained one topo IV holoenzyme for every 50
quenched at the time points indicated above each gel. The blue
all positive supercoils and achieved its final topoisomer distrib
graphically illustrated on the left side of the gels.need for a lower amount of enzyme to fully unlink
the catenated network).
Based on the outcome of this study, we proceeded
to perform time-course reactions of topo IV on kDNA
(Fig. 5). As with the enzyme titrations, topo IV
containing a mutation in blade 2 displayed essen-
tially WT activity. An enhanced ability of the blade 4
and 5 mutations in catalyzing minicircle release was
also seen. The substitution to blade 3 again impaired
minicircle release (~5-fold decrease), while the
blade 1 alteration failed to produce virtually any
detectable minicircle product. Overall, these data
indicate that blade 1 and, to a lesser extent, blade 3
play a critical role in supporting the activity of topo IV
on catenated substrates. Moreover, as with our
positive-supercoil relaxation study, different posi-
tions on the ParC CTD appear to play an unequal
part in the enzyme's decatenation function.
To round out our analysis, we next tested the
ability of our ParC CTD mutants to relax topo IV's
least favored substrate, negatively supercoiled DNA.
As with the experiments using positively supercoiled
substrates, enzyme titrations were first performed to
look at overall catalytic prowess (Fig. 6). Mutations in
nearly every blade led to reproducible changes in the
relative amount of enzyme required to produce
comparable amounts of relaxed product, with the
exception of the mutation to blade 4, which displayed
essentially WT activity. Interestingly, activity wastant topo IVs. The constructs assayed are shown in each
positively supercoiled plasmid molecules. Samples were
box corresponds to the time at which WT topo IV removed
ution and is shown for reference. Topoisomer species are
Fig. 4. General activity of WT and mutant topo IVs on kDNA. The constructs assayed are shown in each panel. Each
assay proceeded for 10 min prior to quenching and contained 9.2 nM of kDNA and various concentrations of each topo IV
construct (0.005–50 nM), with the ratio of topo IV to DNA indicated above each gel. On the left of each gel, a schematic of the
catenated substrate trapped in the wells and the releasedminicircles. Blue boxes correspond to the enzyme concentration at
which WT topo IV appears to have removed a majority of the catenanes from the kDNA substrate. The asterisk above each
gel indicates the concentration at which each topo IV construct was used in time-course experiments (Fig. 5).
3034 Topo IV ParC CTD Controls Substrate Discriminationactually subtly enhanced by the substitutions in
blade 5 (~2- to 3-fold) but reduced by the alterations
made to blades 2 and 3 (~10-fold). The blade 1
mutation nearly completely abolished activity overall
(~20-fold decrease).
To examine these functional effects further, we
performed time-course assays using a fixed molar
ratio of topo IV to DNA (Fig. 7). Since there proved to
be a significant difference in general activity between
the blade 4 and 5 mutants of ParC compared to the
other constructs, we examined activity with two
slightly different enzyme concentrations to observerelaxation within a common time frame (a 1.5-fold
molar excess of DNA to topo IV for blades 4 and 5,
and a 1.3-fold molar excess of topo IV to DNA for
blades 1–3). Under these conditions, we again
observed an enhanced rate of relaxation by the
blade 5 mutant (~2-fold), whereas the blade 4
mutant exhibited WT behavior. By contrast, the
blade 2 and 3 mutants removed negative supercoils
very slowly (~10-fold less quickly), while the blade 1
mutant was incapable of removing negative super-
coils in the time period assayed. These results, as
with the other substrates, indicate that the outer
Fig. 5. Rate of kDNA resolution by WT and mutant topo IVs. The constructs assayed are shown in each panel. Assays
contained approximately 1 topo IV holoenzyme for every 5 kDNA minicircles. Samples were quenched at the time points
indicated above each gel. The blue box corresponds to the time at which the WT topo IV enzyme appeared to have
removed a majority of the catenanes. Illustrated on the left side of each gel is a schematic of the catenated substrate
trapped in the wells and the released minicircles.
3035Topo IV ParC CTD Controls Substrate Discriminationsurface of the ParC CTD is important for the control
of negative-supercoil relaxation but that different
blades again do not contribute equivalently to this
activity.
Different blades on the CTD have a non-equivalent
effect on DNA binding
Because the CTD is thought to be a T-segment
binding element, the functional disparities between
different mutants in our assays suggested that
individual substitutions might be affecting the affinity
of the domain for DNA. To test this idea, we
assessed the ability of different CTD mutants tobind DNA using fluorescence anisotropy. Because
full-length ParC and the topo IV holoenzyme both
bind DNA, we looked at the isolated CTD to establish
the effects of our substitutions on this region alone.
In our initial experiments, we found that the isolated
CTD (498–752) tended to aggregate over time.
Since this domain is well behaved when connected
to the N-terminal DNA binding region of ParC, we
overcame this poor solution behavior by fusing the
CTD to an inert carrier protein, maltose binding
protein (MBP). The MBP-CTD construct proved well
behaved, showing no observable tendency to
aggregate by gel filtration. We then proceeded to
examine the properties of each of our various CTD
Fig. 6. General activity of WT and mutant topo IVs on negatively supercoiled DNA. The constructs assayed are shown
in each panel. Each assay proceeded for 10 min prior to quenching and contained 7.9 nM of a negatively supercoiled
plasmid and various concentrations of each topo IV construct (0.4–50 nM). The ratio of topo IV to DNA indicated above
each gel. A schematic of the topoisomer distribution is illustrated on the left side of the gels. Blue boxes correspond to the
enzyme concentration at which WT topo IV removes all negative supercoils and reaches its final topoisomer distribution.
3036 Topo IV ParC CTD Controls Substrate Discriminationmutants by incubating different concentrations of the
MBP fusion with 20 nM of a fluorescein-labeled 20mer
duplex oligonucleotide. The mutants exhibited a broad
range of DNA binding activity, with the mutations
closest to the N-terminal half of the CTD displaying
near-WT levels of affinity. By contrast, DNA binding
became progressively impaired as substitutions were
made to more C-terminal regions of the domain
(Fig. 8a). Thus, as with activity assays, different
regions of the ParC CTD contributed differently to
DNA binding by the domain. Interestingly, however,
the mutations that most significantly affected DNA
binding did not necessary correlate with substitutions
that showed the greatest effect on enzyme activity.Blade 1 of ParC CTD is required for G-segment
bending
Through the course of conducting our DNA
relaxation and decatenation assays, it became
apparent that one mutant in particular, Arg564Asp
in blade 1, showed greatly impaired activity on all
substrates (N90–95% decreases, comparable to
deletion of the CTD entirely [20]). However, when
we assessed this substitution either in the context of
the CTD alone or in topo IV holoenzyme, it had oneof the least severe effects on DNA binding (Fig. 8a
and b). Given this dichotomy, we were curious as to
whether the mutation might disrupt not T-segment
interactions per se, but rather some other aspect of
topo IV function. Type IIA topoisomerases have
been shown to bend the G-segment DNA [37–45];
inspection of the structure of full-length ParC shows
that Arg564 lies close to the G-segment binding site
of the protein, near the point where the bent DNA
arms emanate from the active site (Supplementary
Fig. 4). This juxtaposition would appear to be
sterically incompatible with the binding of Arg564 to
a T-segment, as the transport DNA would clash with
a bound G-segment.
Based on this structural consideration, we
hypothesized that blade 1 might play a role in
linking the CTD to a G-segment associated with
topo IV. Because the G-segment binding site of
type IIA topoisomerases is large and extensive
(comprising N2500 Å2 of surface area [38,41–
44,46–48]), we did not anticipate observing a
strong defect in G-segment affinity per se, an
expectation borne out by our affinity measurements
(Fig. 8b). Instead, the proximity of blade 1 to the
bent arms of a prospective G-segment suggested
to us that the amino acid might interrogate the
geometry of the associated DNA.
Fig. 7. Rate of negative-supercoil relaxation by WT and mutant topo IVs. The constructs assayed are shown in each
panel. (a–c) Five nanomolar of WT or mutant topo IV was incubated with 7.9 nM of negatively supercoiled plasmid. (d–g)
Ten nanomolar of WT or mutant topo IV was incubated with 7.9 nM of negatively supercoiled plasmid. Samples were
quenched at the time points indicated above each gel. The blue box corresponds to the time at which the WT topo IV
enzyme removed all negative supercoils and achieved its final topoisomer distribution. Topoisomer species are graphically
illustrated on the left side of the gels.
3037Topo IV ParC CTD Controls Substrate DiscriminationTo test this idea, we looked to see whether G-
segment bending might be affected by the integrity of
the CTD using fluorescence resonance energy
transfer (FRET). In these experiments, we utilized
a 45mer duplex oligonucleotide labeled on opposite
strands with Cy3 and Cy5 and the topo IV
holoenzyme. Bending was observed after exciting
Cy3 with 530 nm and observing changes in theemission from 545 to 720 nm. Consistent with earlier
studies, WT topo IV gave rise to a strong FRET
signal consistent with the introduction of a sharp
DNA bend [40,45] (Fig. 8c). By contrast, the
Arg564Asp mutant gave rise to no appreciable
change in FRET, indicating that DNA bending was
severely compromised in this mutant. To confirm this
result, we next tested a ParC construct lacking its
Fig. 8. DNAbinding by theParCCTDandDNAbinding and bending by topo IV. (a) DNAbinding byWTandmutantMBP-
ParC CTD constructs. MBP-ParC CTD was titrated against 20 nM of a fluorescein-labeled 20mer duplex oligonucleotide,
and DNA binding was measured as a function of change in fluorescence anisotropy (ΔFA), as measured in millianisotropy
units (mA). Error bars correspond to the standard deviation between three replicates. Since the MBP-ParC CTD never
achieves fully saturated binding isotherm, only relative dissociation constants can be obtained from this assay (Kd,app: WT,
~5 μM; R564D, ~13 μM; R616D, ~14 μM; K665D, ~26 μM; R723D, ~113 μM; R705D/R729D, ~56 μM). (b) DNA binding
byWT topo IV, Arg564AspParC topo IV, andNTD-ParC topo IV. Topo IVwas titrated against 20 nMof a fluorescein-labeled
45mer duplex oligonucleotide, and DNA binding was measured as a function of change in fluorescence anisotropy (ΔFA),
as measured in millianisotropy units (mA). The Kd,app of WT topo IV is 25 ± 5 nM and that of R564D topo IV is 15 ± 3 nM.
(c) DNA bending by WT topo IV, Arg564Asp ParC topo IV, and NTD-ParC topo IV. Topo IV was titrated against 20 nM of a
45mer duplex, labeled with Cy3 and Cy5. Bending of the oligonucleotide is observed as a change in the relative intensity of
the emission spectra of Cy5 (545–720 nm) after excitation of the Cy3 label at 530 nm (arrow).
3038 Topo IV ParC CTD Controls Substrate DiscriminationCTD entirely. As with the Arg564Asp mutation, this
construct likewise failed to induce any observable
change in FRET, again indicative of a bending
deficiency. Together, these data reveal that the CTD
plays an unexpected role in the establishment of a
stable G-segment bend by topo IV and further
suggest that the significant enzymatic defects we
observe in the Arg564Asp mutant are due at least in
part to this defect.Discussion
Although all type IIA topoisomerases rely on a
generally conserved, ATP-dependent strand pas-
sage mechanism for effecting topological changes in
DNA, the substrate specificities of different enzyme
subfamilies vary significantly. Topo IV discriminates
between topologically distinct DNA substrates in a
manner that requires the CTD of its ParC subunit
[20]; however, the molecular basis for this discrim-ination has remained ill-defined. It has been postu-
lated that the GyrA and ParC CTDs contribute to
substrate discrimination by associating with DNA
substrates using their positively charged outer rim
[18,26]. To better understand how the ParC CTD
might mediate these effects, we identified highly
conserved, basic amino acids on CTD surface and
mutated these regions to aspartate. We then tested
whether these substitutions altered topo IV function
on positively supercoiled, catenated, and negatively
supercoiled DNA substrates, and whether they
altered DNA binding by the isolated domain itself.
Our ParC CTD substitutions reveal an unexpect-
edly rich pattern of functional contributions emanat-
ing from each blade of the domain (Fig. 9). For
example, blade 1 is critical for overall topo IV activity
on all substrates. By contrast, blade 4 is not essential
for general activity on any substrate. Catenane
resolution strongly depends on blade 3, while
efficient removal of negative supercoils (and to a
lesser extent positive supercoils) depends not only
Fig. 9. Schematic of ParC CTD activities according to residue. The ParC CTD surface is painted according to the effect
of mutations on various functional parameters (general activity, rate, and processivity) on specific substrates. (a) Positively
supercoiled DNA. (b) kDNA. (c) Negatively supercoiled DNA. (d) Representative CTD highlighting the effects of mutations
on ParC CTD DNA binding. A color key for each activity is found on the right of each CTD.
3039Topo IV ParC CTD Controls Substrate Discriminationon an intact blade 3 but also on blade 2. In addition to
modulating general topo IV activity, different sub-
stitutions also affected overall processivity, as well
as DNA binding by the isolated CTD. Processivity
defects were most apparent with blade 2 and 3
substitutions, yet milder defects were also observed
upon altering blade 4. We discovered that DNA
binding by the isolated domain was strongly per-
turbed by substitutions to blades 4 and 5, whereas
mutations in other blades had a more subtle impact
on DNA binding (Fig. 8). Interestingly, the blade 5
mutation actually enhanced the activity of topo IV in
relaxing negatively supercoiled DNA and in decate-
nating kDNA substrates, indicating that the strong
DNA binding site associated with blade 5 is actually
an auto-inhibitory element that specifically represses
negative-supercoil relaxation and catenane resolu-
tion. Together, our data show that single mutations
made to the positively charged surface of the CTD
give rise to specific but differential effects on enzymeactivity and processivity depending upon which
blade they reside (Fig. 10a).
Overall, these findings unexpectedly demonstrate
that the ParC CTD is not a uniform, nonspecific DNA
binding domain, but rather a complex sensor
element that can both interrogate the topological
status of DNA and use this information to control
topoisomerase response. An additional surprise is
the finding that one region of the CTD (blade 1) is
required not only for activity on all substrates but also
for the bending of G-segment DNA. At present, it is
unknown how topo IV associates with DNAs outside
of the active site; however, this study clearly
indicates that specificity for and activity differences
on distinct DNA substrates can be attributed to non-
equivalent surfaces of the ParC CTD. It is similarly
unclear whether ParC orthologs whose CTD blade
number varies compared to that of E. coli ParC are
able to discriminate between different DNA
topologies.
Fig. 10. The ParC CTD is a DNA topology discrimination element. (a) Cartoon summary of the effects resulting from
mutating different blades of the ParC CTD. Down arrows indicate that the mutations inhibit (down arrow) topo IV activity on
specific substrates; up arrows indicate a stimulating effect. Abbreviations: SC, supercoiled; resol, resolution; distrib,
distributive; relax, relaxation; (+), positively; (−), negatively. (b) Crystal structure of the ParC dimer (PDB ID: 1ZVU) with G-
segment DNA (purple) (PDB ID: 2RGR) docked into the active site and a T-segment (orange) DNA modeled for
perspective. (c) Model for topo IV's potential interactions with positively supercoiled DNA substrates, front and top views.
The ParC CTD and the DNA are colored as in (a) and (b). The ParC NTD is colored cyan. The NTD of ParE is colored gray,
and the DNA binding C-terminal TOPRIM domain is colored red. DNA is shown associating with surfaces required for
processivity and overall enzyme activity. (d) Model for topo IV's interactions with negatively supercoiled DNA substrates,
front and top views. A nonproductive complex between the fifth blade of the ParC CTD and the T-segment DNA could form
on negatively supercoiled substrate (left panel) if the ParC CTDs remain in the same rotational orientation as in (c)
(illustrated as washed-out CTDs) but were to shift positionally away from a subdomain on the ParC NTD known as the
tower. To engage the T-segment of a negatively supercoiled DNA in a catalytically competent manner (right panel), the
ParC CTD would need to rotate by 180° about a flexible linker.
3040 Topo IV ParC CTD Controls Substrate DiscriminationAn additional outcome of these data is their ability
to help reconcile a debate insofar as how topo IV
discriminates between positively supercoiled and
negatively supercoiled DNA segments. Early single-molecule experiments using braided DNA sub-
strates led to the hypothesis that topo IV could
discriminate between different DNA topologies by
recognizing the chiral juxtaposition between G- and
3041Topo IV ParC CTD Controls Substrate DiscriminationT-segments in the topo IV active site [10]. However,
a subsequent single-molecule study using single
duplex crossovers indicated that topo IV has no
preference for DNA duplex crossing angle and that
lowered enzyme processivity on negatively super-
coiled DNA was instead responsible for the differ-
ence in supercoil relaxation rates between
underwound and overwound substrates [14]. Our
data suggest that topo IV can indeed read out
crossover geometry but that sensing of this geom-
etry occurs outside the active site, where it in-
fluences not only strand passage efficiency but also
enzyme processivity. In this model, positively super-
coiled substrates would interact with blades 2, 3, and
4. Negatively supercoiled DNA would also interact
with blades 2 and 3 but could further associate with a
strong DNA binding site on blade 5 that impedes
strand transport and lowers processivity. Catenated
DNAs would preferentially engage blades 3 and 4,
but likewise be subject to an interaction with blade 5
that slows enzyme function. Blade 1 would play a
role in binding the G-segment as a means to both
facilitate the bending of this DNA through the active
site and help orient the CTD for appropriate readout
of substrate DNA topology.
How might the CTD physically mediate such
differential effects? One possible mechanistic
model for the action of the ParC CTD can be derived
by docking a G-segment from a DNA-bound type IIA
topoisomerase into the structure of the full-length
ParC dimer and modeling T-segment DNA over the
active site (Fig. 10b). Such an exercise indicates that
the ParC CTD likely adopts alternate conformations
with respect to the N-terminal domains (NTDs) to
engage the flanking arms of positive- or negative-
handed T-segment DNAs after they exit the active
site (Fig. 10c and d). The degenerate GyrA box that
resides on the surface of blade 1 would help stabilize
G-segment bending, a property we recently have
found to be critical for enzyme function [45]. The
equivalent motifs in other blades, particularly 2 and
3, would be brought to bear on a T-segment by using
distinct CTD orientations to distinguish between
different types of DNA topologies; when engaged,
these elements would promote processive strand
passage events, as has been seen on positively
supercoiled DNA [10,11,14]. However, in some
instances, particular CTD configurations would
allow the strong DNA-binding site on blade 5 to
counteract the other blades and actively impede
strand transport, possibly by slowing T-segment
release and contributing to the lowered processivity
seen on negatively supercoiled DNA [14]. Although it
is not known at present if the CTDs of topo IV are
mobile, precedence for such movement can be
found in gyrase, whose related domains appear to
transit with a T-segment during strand passage [49–
51]. The suggestion that the ParC CTD interacts with
both the G- and T-segments also has parallels withgyrase, whose CTDs also are known to engage DNA
sufficiently tightly as it exits the nucleolytic active site
that they wrap the duplex back through the enzyme
to provide the transport strand in cis [27]. A more
precise physical model that can account for how an
extended DNA segment can writhe spatially to
selectively engage specific regions of the CTD, as
well as snake through the arms of a second bent
DNA, will require future investigation.Materials and Methods
Cloning and protein expression
Cloning of the full-length coding regions of E. coli ParC
(1–752), ParE (1–630), and the ParC NTD (1–482) has
been previously described [20]. The ParC CTD (498–
752) was amplified from E. coli MG1655 K-12 genomic
DNA and cloned into vector pSV272, which possesses
an N-terminal hexahistidine (His6) tag followed by an
MBP tag and a tobacco etch virus (TEV) protease
cleavable site. Point mutations were introduced into the
full-length ParC or the His6-MBP ParC CTD using
QuikChange (Stratagene).
Proteins (except for the ParC NTD) were overexpressed
in E. coli BL21codon-plus (DE3) RIL cells (Stratagene) at
37 °C. Protein expression was induced at 37 °C by adding
0.25–0.5 mM IPTG to 2xYT liquid media cultures after
cells had grown to OD600 (optical density at 600 nm) =
0.3–0.5. After induction, cells were grown at 37 °C for an
additional 3–4 h, centrifuged, resuspended in buffer A800
[10% (v/v) glycerol, 20 mM Tris–HCl, pH 7.9, 800 mM
NaCl, 30 mM imidazole, pH 8.0, 2 mM β-mercaptoethanol
(BME), 1 μg/mL pepstatin A, 1 μg/mL leupeptin, and
1 mM phenylmethylsulfonyl fluoride (PMSF)], frozen
drop-wise into liquid nitrogen, and stored at −80 °C prior
to purification.
Purification of E. coli ParE and ParC
For purification, cells were thawed, lysed by sonication,
and centrifuged. Clarified lysates were applied to 5-mL
HiTrap Ni2+ columns (GE), and the columns were washed
extensively with buffer A800. The columns were washed
further with A400 [10% (v/v) glycerol, 20 mM Tris–HCl,
pH 7.9, 400 mM NaCl, 30 mM imidazole, pH 8.0, 2 mM
BME, 1 μg/mL pepstatin A, 1 μg/mL leupeptin, and 1 mM
PMSF]. Proteins were eluted in B400 [10% (v/v) glycerol,
20 mM Tris–HCl, pH 7.9, 400 mM NaCl, 500 mM imidaz-
ole, pH 8.0, 2 mM BME, 1 μg/mL pepstatin A, 1 μg/mL
leupeptin, and 1 mM PMSF] and concentrated by centri-
fugation (Millipore Amicon Ultra 30). To remove His6 tags,
we dialyzed the proteins overnight in Slide-A-Lyzer
cassettes (Thermo Scientific, 10K MWCO), at 4 °C against
A400 in the presence of 1 mg of His6 TEV protease
(MacroLab, University of California, Berkeley). Following
TEV cleavage, the proteins were run over HiTrap Ni2+
columns equilibrated in A400 to isolate tagless proteins
and remove the TEV protease. All proteins were concen-
trated by centrifugation (Millipore Amicon Ultra 30) and
applied to an S-300 gel-filtration column (GE) equilibrated
3042 Topo IV ParC CTD Controls Substrate Discriminationand run in SE buffer [10% (v/v) glyercol, 20 mM Tris–HCl,
pH 7.9, 400 mM KCl, 2 mM BME, 1 μg/mL pepstatin A,
1 μg/mL leupeptin, and 1 mM PMSF]. Peak fractions were
collected and concentrated by centrifugation (Millipore
Amicon Ultra 30). Protein purity was assessed by SDS-
PAGE/Coomassie staining, and protein concentration was
measured by absorbance at 280 nm. Proteins were flash
frozen in a final buffer containing 30% (v/v) glycerol,
20 mM Tris–HCl, pH 7.9, 400 mM KCl, and 2 mM BME,
and stored at −80 °C.
Purification of His6-MBP ParC CTD
Cells suspended and frozen in buffer A800 were
thawed, sonicated, and centrifuged. Clarified lysate was
applied to a 5-mL HiTrap Ni2+ column (GE) equilibrated in
buffer A800. The column was washed in buffer A800
followed by buffer A400. Protein was eluted from the Ni2+
column directly onto a 10-mL amylose column in B400
(New England Biolabs). The amylose column was then
washed in buffer C [10% (v/v) glycerol, 20 mM Tris,
pH 7.9, 400 mM NaCl, 2 mM BME, 1 μg/mL pepstatin A,
1 μg/mL leupeptin, and 1 mM PMSF] and proteins were
eluted from the amylose column in buffer D [10% (v/v)
glycerol, 20 mM Tris, pH 7.9, 400 mM NaCl, 2 mM BME,
100 mMmaltose, 1 μg/mL pepstatin A, 1 μg/mL leupeptin,
and 1 mM PMSF]. Peak fractions were collected and
concentrated by centrifugal filtration (Millipore Amicon
Ultra 30). Protein was then run over an S-300 size-
exclusion column equilibrated and run in SE buffer. Peak
fractions were collected, concentrated by centrifugation
(Millipore Amicon Ultra 30), flash frozen, and stored at −
80 °C. The protein was stored in a final buffer containing
30% (v/v) glycerol, 20 mM Tris–HCl, pH 7.9, 400 mM KCl,
and 2 mM BME. Protein purity was assessed by
SDS-PAGE/Coomassie staining, and protein concentra-
tion was measured by absorbance at 280 nm.
Expression and purification of the ParC NTD
The ParC NTD was overexpressed in E. coli BL21co-
don-plus (DE3) RIL cells (Stratagene) from a fresh
transformation. Protein expression was induced at 30 °C
by adding 0.3 mM IPTG to 1-L 2xYT liquid media cultures
after cells had grown to OD600 = 0.3–0.5. Cells were
grown for six more hours, resuspended in A800, drop
frozen, and stored at −80 °C.
For purification of the ParC NTD, cells were thawed,
lysed by sonication, and centrifuged. The clarified lysate
was applied to a 5-mL HiTrap Ni2+ column (GE), and the
column was washed extensively with a buffer containing
800 mM NaCl, 10 mM imidazole, pH 8.0, 50 mM Tris–
HCl, pH 7.9, 20% (v/v) glycerol, 2 mM BME, 1 μg/mL
pepstatin A, 1 μg/mL leupeptin, and 1 mM PMSF. The
column was then washed in buffer A200 [200 mM NaCl,
10 mM imidazole, pH 8.0, 50 mM Tris–HCl, pH 7.9, 20%
(v/v) glycerol, 2 mM BME, 1 μg/mL pepstatin A, 1 μg/mL
leupeptin, and 1 mM PMSF]. The protein was eluted in a
buffer containing 200 mM NaCl, 400 mM imidazole,
pH 8.0, 50 mM Tris–HCl, pH 7.9, 20% (v/v) glycerol,
2 mM BME, 1 μg/mL pepstatin A, 1 μg/mL leupeptin, and
1 mM PMSF and concentrated by centrifugation (Millipore
Amicon Ultra 30). To remove the His6 tag, we dialyzed the
protein overnight in Slide-A-Lyzer cassettes (ThermoScientific, 10K MWCO), at 4 °C against A200 in the
presence of 1 mg of His6 TEV protease. Following TEV
cleavage, the protein was run over a HiTrap Ni2+ column
equilibrated in A200 to isolate tagless proteins and remove
the tagged TEV protease. The protein was concentrated
by centrifugation (Millipore Amicon Ultra 30) and then
applied to an S-300 gel filtration column (GE) equilibrated
and run in a buffer containing 800 mM KCl, 50 mM Tris–
HCl, pH 7.9, 20% (v/v) glycerol, 2 mM BME, 1 μg/mL
pepstatin A, 1 μg/mL leupeptin, and 1 mM PMSF. Peak
fractions were collected and concentrated by centrifuga-
tion (Millipore Amicon Ultra 30). The ParC NTD was flash
frozen in a final buffer containing 30% (v/v) glycerol,
20 mM Tris–HCl, pH 7.9, 400 mM KCl, and 2 mM BME,
and stored at −80 °C. Protein purity was assessed by
SDS-PAGE/Coomassie staining, and protein concentra-
tion was measured by absorbance at 280 nm.
Circular dichroism
Aliquots of full-length WT and mutant ParCs were
thawed and dialyzed overnight at 4 °C against a buffer
containing 200 mM KCl and 10 mM Tris–HCl, pH 7.9.
After dialysis, the proteins were diluted to a final
concentration of 0.25 mg/mL. CD spectra were taken at
25 °C and 37 °C with an Aviv model 410 Circular
Dichroism Spectrophotometer in a 1-cm pathlength cu-
vette. Data were obtained from 250 to 200 nm, at 1-nm
intervals. Each point is averaged over 5 s and each read
was performed three times.Preparation of supercoiled plasmid substrates
and kDNA
Negatively supercoiled pSG483 (2927 bp), a pBlue-
script SK derivative, was prepared from E. coli using a
maxiprep kit (Machery-Nagel). To produce positively
supercoiled pSG483, we treated negatively supercoiled
pSG483 with Archaeoglobus fulgidus reverse gyrase
following the method of Rodriguez [52]. kDNA from
Crithidia fasciculata was purified as described by Shapiro
et al. [53].DNA supercoil relaxation assays and decatenation
assays
The topo IV holoenzyme was formed on ice by
incubating equimolar amounts of ParE and ParC (tetramer
final concentration ~20–40 μM) for 10 min. Topo IV was
then serially diluted in protein dilution buffer [2- to 3-fold
steps in 150 mM potassium glutamate, 50 mM Tris–HCl,
pH 7.9, 10% (v/v) glycerol, and 6 mM MgCl2] and mixed
with supercoiled DNA (7.9 nM final concentration) or
kDNA (9.2 nM). The final reaction (20 μL) contained
30 mM potassium glutamate, 1% (v/v) glycerol, 10 mM
dithiothreitol (DTT), 1 mM spermidine, 10 μg/mL bovine
serum albumin (BSA), 50 mM Tris–HCl, pH 7.9, 6 mM
MgCl2, and 2 mM ATP, pH 7.5. For enzyme titration
experiments, samples were incubated at 37 °C for
10 min after addition of ATP. The reactions were
quenched by the addition of 2% (w/v) SDS and 20 mM
ethylenediaminetetraacetic acid (EDTA), pH 8.0 (final
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samples, which were then run on 1% (w/v) TAE agarose
gels (40 mM sodium acetate, 50 mM Tris–HCl, pH 7.9,
and 1 mM EDTA, pH 8.0) for 6–15 h at 2–2.5 V/cm. For
visualization, gels were stained with 0.5 μg/mL ethidium
bromide in 1% TAE buffer for 20 min and then destained in
1% TAE buffer for 30 min and exposed to UV transillumi-
nation. For time-course experiments, the reaction volume
was increased to 180 μL. After the addition of ATP,
samples were incubated at 37 °C. For each time point,
18 μL of the sample was removed and quenched by the
addition of 2% (w/v) SDS and 20 mM EDTA, pH 8.0 (final
concentrations). All other experimental parameters are
identical to those utilized in the enzyme titration experi-
ments. All gel-based experiments were performed at least
three times with at least two different protein preparations
for each ParC construct.
DNA binding experiments with the isolated His6-MBP
ParC CTD
A randomly generated, 20-bp annealed duplex oligonu-
cleotide was purchased from Integrated DNA Technolo-
gies (IDT) and resuspended in water (50% G/C content,
Tm = 50 °C, 5′-|56-FAM|-TTAGGCGTAAACCTCCATGC-
3′ and 5′-GCATCCGCATTTACGCCTAA-3′, where |56-
FAM| indicates the position of a carboxyfluorescein dye
used for analysis). A short DNA was chosen to prevent
binding of the multiple CTDs to a single duplex. All proteins
were diluted on ice in protein dilution buffer A [150 mM
potassium glutamate, 20 mM Tris–HCl, pH 7.5, 10% (v/v)
glycerol, and 50 μg/mL BSA]. The assay (80 μL) contained
16 μL of the diluted His6-MBP ParC CTD protein and
20 nM of the fluorescently labeled 20mer oligonucleotide.
DNA and proteins were initially incubated on ice in the dark
for 10 min, after which they were diluted to the final assay
volume and kept at room temperature in the dark for 10–
15 min [final assay conditions: 2.4 mM DTT, 20 mM Tris–
HCl, pH 7.5, 10% (v/v) glycerol, 1 mM MgCl2, 50 μg/mL
BSA, and 30 mM potassium glutamate]. Measurements
were made with a Perkin Elmer Victor 3V 1420 multilabel
plate reader at 535 nm. Data points are the average of
three independent experiments and all points are normal-
ized to wells where protein is absent. Data were plotted in
GraphPad Prism Version 5 using the following single-site
binding model equation:
Y¼Bmax
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where Bmax is the maximum specific binding, [L] is the DNA
concentration, [P] is the concentration of the His6-MBP
ParC CTD, and Kd,app is the apparent dissociation
constant for His6-MBP ParC CTD and DNA [54,55].
DNA binding experiments with the topo IV holoenzyme
The topo IV holoenzyme was reconstituted as described
for the DNA relaxation and decatenation assays. A 45-bp
annealed duplex DNA with a strong topoisomerase II
binding site was obtained from IDT and resuspended in
water [56]. The sequences for the two strands were 5′-GCCTATCCGAGGATGACGATGCGCGCATCGTCATA-
CAGCGAATGG-3′ and 5′-|56-FAM|-CCATTCGCTGTAT-
GACGATGCGCGCATCGTCATCCTCGGATAGGC-3′.
A longer DNA was chosen for this study because the
central DNA binding and cleavage core of type IIA
topoisomerases footprints an ~34-bp span of the duplex
[57]; the DNA was extended slightly further to match the
oligo used for obtaining a robust FRET signal in our recent
DNA bending studies [45]. To conduct the assay, we
titrated topo IV on ice and mixed it with DNA (20 nM final)
for 10 min prior to further dilution. The final reaction (80 μL)
contained 25 mM Tris–HCl, pH 7.5, 20 mM NaCl, 10 mM
MgCl2, 10% (v/v) glycerol, and 100 μg/mL BSA. Reactions
were incubated at room temperature for 15 min prior to
taking measurements. Measurements were made with a
Perkin Elmer Victor 3V 1420 multilabel plate reader at
535 nm. Data were plotted in Prism GraphPad Version 5
and fit to the single-site binding model described earlier.
FRET-based DNA bending experiments
A 45mer duplex DNA of identical sequence to that
employed for the binding assays was used to conduct the
bending experiments. One strand contained a 5′-Cy5 dye
(5′-GCCTATCCGAGGATGACGATGCGCGCATCGTCA-
TACAGCGAATGG-3′) while the other bore a 5′-Cy3 label
(5 ′-CCATTCGCTGTATGACGATGCGCGCATCGT-
CATCCTCGGATAGGC-3′).
For the assay, 0–1000 nM topo IV was titrated against
100 nM labeled DNA in 14-μL reactions containing 25 mM
Tris–HCl, pH 7.5, 20 mM NaCl, 10 mM MgCl2, 10% (v/v)
glycerol, and 100 μg/mL BSA. Emission spectra of Cy5
(545–720 nm) were measured after excitation of Cy3 by
530 nm using a Fluoromax fluorometer 4 (HORIBA Jobin
Yvon, Edison, NJ, USA). The loss of emission signal with
topo IV constructs containing either the blade 1 ParC
mutant or the ParC NTD alone reflects a loss of the ability
of the enzyme to bend DNA [40,45].
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